Drug application
ORTHO-NOVUM 7/7/7-21 (ETHINYL ESTRADIOL, NORETHINDRONE)
Drugs@FDA NDA 018985 · JANSSEN PHARMS
Key facts
| Drug name | ORTHO-NOVUM 7/7/7-21 |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL, NORETHINDRONE |
| Application type | NDA |
| Application number | 018985 |
| Company | JANSSEN PHARMS |
| Dosage forms | TABLET, ORAL-21 |
| Strength | 0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Apr 4, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: